Kallelse till årsstämma i SmartCella Holding AB
SmartCella represents business sector in Swedish Government delegation to Boston
SmartCella och Catalent tecknar icke-exklusivt licensavtal för GMP-iPSCs
SmartCella and Catalent sign nonexclusive license agreement for GMP iPSCs
SmartCella appoints Professor Jan Lundberg to Scientific Advisory Board
Första patienten behandlad i XyloCor Therapeutics fas IIb-studie med SmartCellas leveransplattform Extroducer
First patient dosed in XyloCor Therapeutics’ Phase IIb trial using SmartCella’s Extroducer delivery platform
SmartCella forms Scientific Advisory Board with leading global scientific experts
SmartCella bildar vetenskapligt råd med ledande globala vetenskapliga experter
Kallelse till extra bolagsstämma i SmartCella Holding AB
Let’s pioneer the future of targeted therapies together